How to Avoid Approval Delays in Japan
This article was originally published in RAJ Devices
Brad Hossack, vice president of international regulatory affairs at Boston Scientific, has many tips on how best to manage the intricacies of the Japanese regulatory approval process. Neena Brizmohun reports.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.